Cyberonics Cuts Investment In VNS Depression Indication; Q4 Sales Up 64%
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics expects to scale-back its investment in developing a depression indication for its NeuroCybernetic Prosthesis vagus nerve stimulation system by 25% in fiscal 2003